Skip to main content
Banner - Research & Funding

PS-ON Funding Opportunities

Title Announcement Number Upcoming Application Receipt Date(s) Expiration Date Activity Code
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-19-113 Standard Dates 07/08/2022 R01
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) PAR-20-074 10/26/2021; 02/28/2022; 07/11/2022; 10/28/2022 10/29/2022 R01
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) PAR-19-287 11/15/2021 11/16/2021 U01
Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) RFA-CA-21-049 11/12/2021 11/13/2021 U24
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed) RFA-CA-21-053 11/01/2021 11/02/2021 U24
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 11/12/2021; 10/19/2022 10/20/2022 U54
Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed) RFA-CA-21-052 11/01/2021 11/02/2021 U54

Past PS-ON Funding Opportunities

Title Announcement Number Expiration Date Activity Code
Physical Sciences – Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) PAR-19-101 10/01/2020 U01
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01) PAR-17-171 12/17/2018 R01
Physical Sciences – Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01) PAR-15-021 09/22/2017 U01
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01) PAR-16-105 01/27/2017 U01
Physical Sciences – Oncology Network (PS-ON): Physical Sciences-Oncology Centers (PS-OC) (U54) PAR-14-169 11/26/2015 U54
Physical Science-Oncology Centers (U54) RFA-CA-09-009 03/14/2009 U54
  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “PS-ON Funding Opportunities was originally published by the National Cancer Institute.”